Palmitoylethanolamide (PEA): A promising biomarker for coronary dysfunction in MOB individuals.
Sign Up to like & getrecommendations! Published in 2017 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2017.04.098
Abstract: Article history: Received 27 February 2017 Received in revised form 11 March 2017 Accepted 26 April 2017 ed. Secondly, the evidence of PEA associated with disease severity was unwarranted. Finally, the cost-effectiveness of PEA as… read more here.
Keywords: pea promising; promising biomarker; biomarker; palmitoylethanolamide pea ... See more keywords
Palmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer’s Disease
Sign Up to like & getrecommendations! Published in 2019 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2019.00821
Abstract: N-Palmitoylethanolamide (PEA) is a non-endocannabinoid lipid mediator belonging to the class of the N-acylethanolamine phospolipids and was firstly isolated from soy lecithin, egg yolk, and peanut meal. Either preclinical or clinical studies indicate that PEA… read more here.
Keywords: therapeutic agent; alzheimer disease; palmitoylethanolamide pea;
Engineered Lactobacillus paracasei Producing Palmitoylethanolamide (PEA) Prevents Colitis in Mice
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms22062945
Abstract: Palmitoylethanolamide (PEA) is an N-acylethanolamide produced on-demand by the enzyme N-acylphosphatidylethanolamine-preferring phospholipase D (NAPE-PLD). Being a key member of the larger family of bioactive autacoid local injury antagonist amides (ALIAmides), PEA significantly improves the clinical… read more here.
Keywords: lactobacillus paracasei; pea; engineered lactobacillus; paracasei producing ... See more keywords
Effects of Ultramicronized Palmitoylethanolamide (um-PEA) in COVID-19 Early Stages: A Case–Control Study
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceuticals"
DOI: 10.3390/ph15020253
Abstract: Ultramicronized palmitoylethanolamide (um-PEA), a compound with antioxidant, anti-inflammatory and neuroprotective properties, appears to be a potential adjuvant treatment for early stages of Coronavirus disease 2019 (COVID-19). In our study, we enrolled 90 patients with confirmed… read more here.
Keywords: control; group; palmitoylethanolamide pea; ultramicronized palmitoylethanolamide ... See more keywords